Carl June
General Practice · Philadelphia, PA
CMS Profile ID: 334570 · NPI: 1386687689
Total Disclosed General Payments
$8,990,540.46
General-payment records
5
CMS Program Year
2025
Most of this (more than 99%) was acquisition payments.
Payments by Type
| Payment Type | Amount |
|---|---|
| Acquisitions | $8,978,680.46 |
| Consulting Fee | $11,860.00 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| ABBVIE INC. | $8,978,680.46 |
| AstraZeneca Pharmaceuticals LP | $5,840.00 |
| Gilead Sciences, Inc. | $4,195.00 |
| AstraZeneca UK Limited | $1,825.00 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2025 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by exact NPI 1386687689 on the
official CMS Open Payments portal.
Verify this record with CMS
- Confirm the provider's exact NPI: 1386687689.
- Select program year 2025 and general payments in the CMS portal.
- Check individual payment records and their nature-of-payment categories.